WebNews
Please enter a web search for web results.
NewsWeb
NRx Reports FDA Feedback, Progress on Ketamine Application
9+ hour, 59+ min ago (293+ words) WILMINGTON, DE " NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) recently received a Discipline Review Letter from the U. S. Food and Drug Administration identifying only minor administrative changes for its ketamine application and held a meeting with FDA leadership supporting potential approval within the…...
Madrigal to Report Q1 2026 Results May 6, Host Webcast
7+ hour, 59+ min ago (151+ words) CONSHOHOCKEN, PA " Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) will release its first-quarter 2026 financial results on Wednesday, May 6, 2026, before U. S. markets open and will host a webcast at 8 a. m. Eastern Time. The company said a replay will be available approximately two hours after the…...
Neuronetics Schedules Q1 2026 Earnings Release and Call
23+ hour, 59+ min ago (182+ words) MALVERN, PA " Neuronetics, Inc. (NASDAQ: STIM) plans to release its first-quarter 2026 financial and operating results before market open on Tuesday, May 5, 2026, and will host a conference call at 8: 30 a. m. Eastern Time the same day. Participants may register to join the call…...
FDA Moves to Fast-Track Psychedelic Mental Health Treatments
15+ hour, 59+ min ago (482+ words) WASHINGTON, D. C. " Federal health officials are moving to speed the development of psychedelic-based treatments for serious mental illness, following a new executive order aimed at expanding access to emerging therapies. The U. S. Food and Drug Administration announced a series of regulatory actions…...
Student Parents May Gain Child Care Help Under New Grants
19+ hour, 59+ min ago (404+ words) WASHINGTON, D. C. " Low-income college students with children could receive expanded access to campus child care services under a new federal grant competition announced for fiscal year 2026. The U. S. Departments of Education and Health and Human Services announced the latest round of the…...
Aprea Abstract Accepted for ASCO on APR-1051 Phase 1 Study
18+ hour, 59+ min ago (239+ words) DOYLESTOWN, PA " Aprea Therapeutics, Inc. (Nasdaq: APRE) will present early results from a Phase 1 clinical trial of its WEE1 inhibitor APR-1051 at the 2026 American Society of Clinical Oncology Annual Meeting in Chicago. The presentation will feature findings from the first-in-human ACESOT…...
FTC Halts Fake Health Plans That Left Patients Exposed
19+ hour, 59+ min ago (547+ words) WASHINGTON, D. C. " A federal court has temporarily shut down a nationwide operation accused of posing as government agencies and major insurers to sell misleading health plans that left consumers with unexpected medical costs. Last week's action, requested by the Federal Trade…...
Sallie Mae Advises Families on Comparing College Financial Aid Offers
1+ day, 7+ hour ago (299+ words) NEWARK, DE " Sallie Mae (Nasdaq: SLM) is advising students and families on how to compare college financial aid offers as acceptance letters arrive and decisions about enrollment are made. Financial aid letters, issued after students complete the Free Application for…...
Gaming and Leisure Properties Reports First-Quarter Results
18+ hour, 59+ min ago (396+ words) WYOMISSING, PA " Gaming and Leisure Properties, Inc. (Nasdaq: GLPI) recently reported financial results for the quarter ended March 31, 2026, showing increases in revenue, net income, and funds from operations compared to the prior year. Total revenue rose to $420. 0 million from $395. 2 million…...
NEXGEL Closes Celularity Asset Deal, Launches Bio NX Surgical
21+ hour, 59+ min ago (245+ words) LANGHORNE, PA " NEXGEL, Inc. (NASDAQ: NXGL) recently closed its previously announced license and acquisition of a portfolio of regenerative biomaterial products from Celularity Inc. (NASDAQ: CELU) and launched a new division, Bio NX Surgical, to expand its presence in regenerative…...